Jump to main content
Jump to site search

Issue 29, 2014
Previous Article Next Article

A targeted theranostic platinum(iv) prodrug containing a luminogen with aggregation-induced emission (AIE) characteristics for in situ monitoring of drug activation

Author affiliations

Abstract

A targeted theranostic platinum(IV) prodrug based on a luminogen with aggregation-induced emission (AIE) characteristics was developed for selective and real-time monitoring of drug activation in situ.

Graphical abstract: A targeted theranostic platinum(iv) prodrug containing a luminogen with aggregation-induced emission (AIE) characteristics for in situ monitoring of drug activation

Back to tab navigation

Supplementary files

Article information


Submitted
16 Dec 2013
Accepted
19 Feb 2014
First published
19 Feb 2014

Chem. Commun., 2014,50, 3868-3870
Article type
Communication

A targeted theranostic platinum(IV) prodrug containing a luminogen with aggregation-induced emission (AIE) characteristics for in situ monitoring of drug activation

Y. Yuan, Y. Chen, B. Z. Tang and B. Liu, Chem. Commun., 2014, 50, 3868
DOI: 10.1039/C3CC49516G

Social activity

Search articles by author

Spotlight

Advertisements